Pharmaceutical Contract Manufacturing in India: How to Plan Technology Transfer Before Production

Pharmaceutical Contract Manufacturing in India: How to Plan Technology Transfer Before Production

• Medical
• October 26, 2026

What Is Technology Transfer in Pharmaceutical Manufacturing?

Technology transfer is the organised transfer of product, process and testing knowledge between the parties responsible for sending and receiving that knowledge.

It may involve moving a product from development to manufacturing or transferring an established process between manufacturing sites.

The sending unit provides relevant knowledge and supporting records. The receiving unit demonstrates that it can perform the agreed activities under suitable controlled conditions.

Core Transfer Areas Include:

• Product and formulation knowledge.
• Raw material and packaging specifications.
• Manufacturing instructions and process controls.
• Analytical procedures and laboratory capability.
• Equipment and facility suitability.
• Cleaning procedures.
• Qualification and validation requirements.
• Personnel training.
• Documentation and change control.
• Transfer acceptance and approval.

WHO describes technology transfer as a planned activity supported by documentation, professional expertise and a functioning quality system. cdn.who.int

Define the Product and Transfer Scope

Start by identifying exactly what will move to the receiving manufacturer.

A project covering manufacturing, testing and packaging requires different arrangements from one limited to packaging an existing bulk product.

Information to Record:

• Product name and development code where applicable.
• Active ingredient or ingredients.
• Strength.
• Dosage form.
• Proposed batch size or batch-size range.
• Manufacturing steps included.
• Testing activities included.
• Packaging configuration.
• Intended markets.
• Current development or commercial status.

Identify exclusions clearly.

If stability testing, artwork approval or raw material procurement remains with another organisation, record that responsibility in the project plan.

Confirm the Regulatory Position Before Scheduling Production

The regulatory team should assess how the proposed manufacturing arrangement affects the product and intended markets.

The requirements depend on the product, manufacturing activity, site and destination market. A manufacturing agreement alone does not establish permission to supply a medicine.

Questions to Resolve:

• Is the receiving site appropriately authorised for the proposed activities?
• Does the product require additional permissions?
• Does the transfer change information in an existing regulatory dossier?
• Are submissions, notifications or approvals required?
• What evidence must support the proposed site or process change?
• Which activities can proceed while regulatory work remains open?
• What conditions must be met before commercial distribution?

For products manufactured in India for export, assess both the applicable Indian requirements and those of the destination market.

Keep regulatory milestones separate from technical transfer milestones.

Assign Sending and Receiving Responsibilities

Identify the people who will provide information, assess it and approve the transfer outcomes.

Avoid leaving technical decisions to general commercial correspondence.

Functions to Involve Include:

• Product development or formulation specialists.
• Manufacturing personnel.
• Quality assurance.
• Quality control.
• Engineering and maintenance.
• Validation specialists.
• Regulatory affairs.
• Procurement and supply chain.
• Packaging specialists.
• Project management.

Assign an owner and approver to each deliverable.

Where the product owner, knowledge holder and contract manufacturer are different organisations, explain how information and decisions will pass between them.

Agree on Confidentiality and Quality Responsibilities

Establish how confidential information and manufacturing responsibilities will be managed before sharing the technical package.

Commercial terms and quality responsibilities should be documented clearly and remain consistent.

Agreement Topics Include:

• Ownership and permitted use of technical information.
• Confidentiality and access controls.
• Responsibilities for supplying and reviewing documents.
• Material sourcing and supplier approval.
• Deviation investigations.
• Change notification and approval.
• Use of subcontractors.
• Record retention and access.
• Complaint and recall support.
• Batch review and release responsibilities.

Confirm who can authorise changes to the formulation, process, analytical methods and packaging.

A delivery deadline should not override an unresolved quality requirement.

Prepare a Controlled Technical Transfer Package

Provide an organised set of approved documents with clear version identification.

A collection of unverified files can create uncertainty about which instructions the receiving site should follow.

Documents to Discuss Include:

• Product development reports.
• Formulation and manufacturing formula.
• Process description and flow diagram.
• Material specifications.
• Manufacturing instructions.
• In-process controls and acceptance criteria.
• Finished product specifications.
• Analytical procedures and validation records.
• Relevant batch history.
• Stability information.
• Packaging specifications.
• Cleaning information.
• Known deviations and process limitations.

Record missing information in a gap register.

Previous manufacturing experience is useful when its supporting records are available and relevant to the proposed process.

Explain Critical Product and Process Knowledge

The receiving manufacturer needs to understand why important process controls exist.

Instructions such as “mix until uniform” may be insufficient without a defined endpoint and a suitable assessment method.

Knowledge to Transfer Includes:

• Critical quality attributes of the product.
• Material characteristics that influence performance.
• Critical process parameters.
• Established operating ranges.
• Sampling locations and timing.
• In-process acceptance criteria.
• Hold times and storage conditions.
• Known sensitivity to heat, moisture, light or oxygen.
• Previous manufacturing difficulties.
• Actions required when results fall outside expectations.

Distinguish established knowledge from assumptions that still require investigation.

Do not present a successful development batch as proof that every proposed commercial condition is acceptable.

Assess Facility and Equipment Suitability

Compare the sending process with the receiving site’s actual capabilities.

Equipment with a similar name or capacity may operate differently.

Assessment Points Include:

• Equipment design and operating principle.
• Working capacity and loading limits.
• Product-contact materials.
• Mixing, heating and cooling capabilities.
• Process monitoring and data recording.
• Utilities and environmental controls.
• Material and personnel flows.
• Cleaning access and procedures.
• Containment requirements.
• Maintenance and qualification status.

Evaluate how identified differences could affect product quality.

For sterile or highly potent products, include the specialised contamination-control or containment assessments relevant to the product and process.

Hypothetical Equipment Comparison:

Copying settings from the sending site without assessing equipment differences may produce a different process outcome.

Confirm Raw Material and Packaging Readiness

Check that the receiving site can obtain, identify, test and release suitable materials before planned batches begin.

Matching the material name alone is insufficient.

Material Checks Include:

• Approved specification and grade.
• Proposed manufacturer and supplier.
• Relevant physical and chemical characteristics.
• Sampling and testing requirements.
• Storage conditions.
• Retest or expiry controls.
• Procurement lead times.
• Approved alternatives where established.
• Container and closure specifications.
• Compatibility with the proposed packaging process.

A change in active ingredient properties or excipient characteristics can affect processing and product performance.

Assess proposed substitutions through the applicable change-control process.

Plan Analytical Method Transfer

The receiving laboratory needs suitable procedures, equipment, reference materials and trained analysts.

Receiving a written method does not by itself demonstrate the ability to perform it reliably.

Planning Points Include:

• Methods included in the transfer.
• Current method versions.
• Validation or verification status as applicable.
• Laboratory equipment and software requirements.
• Reference standards and reagents.
• Sample preparation instructions.
• Analyst training.
• Transfer study design.
• Acceptance criteria.
• Investigation of unexpected results.

Select and justify the transfer approach for each method.

Complete the relevant laboratory readiness work before relying on the receiving laboratory’s results for manufacturing or release decisions.

Write the Transfer Protocol Before Execution

Prepare an approved protocol that explains how the transfer will be performed and assessed.

Acceptance criteria should be established before reviewing the outcomes.

The Protocol Should Address:

• Objective and scope.
• Product and site identification.
• Responsibilities.
• Required documents.
• Readiness prerequisites.
• Planned studies and batches.
• Sampling and testing arrangements.
• Acceptance criteria.
• Deviation handling.
• Change control.
• Reporting and approval requirements.

Avoid using a protocol that only lists dates and batch quantities.

The document should connect each activity with the evidence needed to judge its outcome.

Separate Trial Batches From Commercial Readiness

Engineering or trial batches may help investigate equipment behaviour and refine operating instructions.

They should have a defined purpose and documented status.

Before Each Batch, Confirm:

• Why the batch is being manufactured.
• Which instructions apply.
• What data will be collected.
• Which tests will be performed.
• How deviations will be managed.
• Whether the batch has any permitted commercial use.
• Who will approve its disposition.

A successful trial batch does not automatically establish process validation or permission for commercial release.

Define the required qualification and validation programme according to the product, process knowledge, risks and applicable requirements.

Plan Qualification, Validation and Stability Activities

Identify the evidence needed to support the receiving site’s proposed manufacturing arrangement.

Do not assume that studies from another site resolve every receiving-site requirement.

Activities to Assess Include:

• Facility, utility and equipment qualification.
• Process performance qualification or other applicable validation work.
• Cleaning validation.
• Analytical method readiness.
• Relevant hold-time studies.
• Packaging process qualification or validation.
• Transport studies where relevant.
• Stability commitments supporting the transfer.
• Continued process monitoring.

Document the rationale for using existing evidence and identify any additional work required.

The number and design of studies should follow a justified approach rather than an unsupported standard assumption.

A Practical Technology Transfer Planning Checklist

Build the Timeline Around Readiness Milestones

Schedule the project around dependencies.

A planned production date is unreliable if materials, methods or equipment are not ready.

Recommended Sequence:

1. Define the product, scope and intended markets.
2. Complete the initial technical and regulatory gap assessment.
3. Agree on responsibilities and required documents.
4. Resolve critical facility, equipment and material gaps.
5. Prepare methods, training and approved protocols.
6. Execute the authorised transfer and validation activities.
7. Investigate deviations and assess the results.
8. Approve the transfer outcome and commercial readiness.

Some activities can run in parallel, but dependent activities need clear entry conditions.

Include time for document review, procurement, investigations and repeat work where justified.

Document Deviations and Transfer Changes

Record differences between the approved plan and actual execution.

An unexpected result should trigger an assessment of its cause and potential effect on the transfer conclusion.

Useful Fields Include:

• Product and project reference.
• Activity or batch affected.
• Description of the issue.
• Supporting data.
• Immediate controls.
• Investigation owner.
• Product and process impact assessment.
• Corrective actions.
• Need for additional studies.
• Approval and closure status.

Assess changes to equipment, materials or operating conditions before incorporating them into routine instructions.

Do not revise acceptance criteria retrospectively simply to make an unsuccessful study appear acceptable.

Common Technology Transfer Mistakes to Avoid

Treating the Formula as the Complete Transfer Package

Include process knowledge, analytical procedures, controls and supporting history.

Assuming Similar Equipment Produces Identical Results

Assess differences in design, scale and operating behaviour.

Leaving Analytical Transfer Until Manufacturing Starts

Prepare the laboratory in time to support the planned studies and decisions.

Changing Suppliers Without Assessing the Impact

Review relevant material characteristics and approval requirements.

Using Trial Batch Success as Automatic Validation

Judge each activity against its defined purpose and acceptance criteria.

Starting Work With Unapproved Instructions

Use controlled documents and record authorised changes.

Closing the Project With Unresolved Critical Gaps

Identify what remains open and whether it prevents the next activity or commercial supply.

Coordinating Technology Transfer With Zircon Medtech

Businesses discussing pharmaceutical contract manufacturing with Zircon Medtech should establish the proposed manufacturing arrangement and identify the parties responsible for technical transfer.

Confirm who holds the product knowledge, which site will receive it and who will approve the resulting evidence.

Request Written Confirmation of:

• Product and manufacturing scope.
• Proposed receiving manufacturer and site.
• Technical contacts at each organisation.
• Documents available for transfer.
• Confidentiality arrangements.
• Material sourcing responsibilities.
• Analytical method transfer responsibilities.
• Trial and validation batch arrangements.
• Regulatory coordination.
• Quality approval and release responsibilities.
• Expected milestones and dependencies.

Confirm the proposed services and responsibilities for the specific project rather than assuming one organisation performs every activity.

Turning Technology Transfer Into Production Readiness

Pharmaceutical contract manufacturing in India benefits from a transfer plan that connects product knowledge with the receiving site’s demonstrated capability.

Define the scope, assess gaps and agree on responsibilities before executing the planned studies. Review results, resolve significant deviations and document the authorised transfer conclusion.

A controlled handover gives the manufacturing partners a clear basis for progressing to commercial production once the applicable technical, quality and regulatory conditions have been satisfied.